Completed NA INTERVENTIONAL 2-arm NCT04332029

Smoking Cessation Treatment for Smokers With Obesity

Sponsor: European Regional Development Fund

Updated 9 times since 2020 Last updated: Nov 28, 2023 Started: Oct 7, 2020 Primary completion: Dec 31, 2022 Completion: Feb 28, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04332029, this NA trial focuses on Tobacco Use Disorder and remains completed. Sponsored by European Regional Development Fund, it has been updated 9 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

9 versions recorded

Jun 2025 — Present [monthly]

Completed NA
Sep 2024 — Jun 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Dec 2023 — Jul 2024 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Jun 2022 — Dec 2023 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting

▶ Show 4 earlier versions

Jan 2021 — Jun 2022 [monthly]

Recruiting NA
Dec 2020 — Jan 2021 [monthly]

Recruiting NA
Oct 2020 — Dec 2020 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
May 2020 — Oct 2020 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

European Regional Development Fund
Ministerio de Ciencia e Innovación, Spain
State Research Agency, Spain
University of Oviedo

Data source: University of Oviedo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Oviedo, Spain